January 25, 2021
Chugai Pharmaceutical will independently promote and market its osteoporosis treatment Edirol (eldecalcitol) after ending its 10-year sales collaboration with Taisho Pharmaceutical on April 10, the two companies said on January 22. Chugai, which is majority held by Roche, is the...read more